82
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

, , , &
Pages 593-598 | Published online: 07 Oct 2013

References

  • SpencerFAEmeryCLessardDThe Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolismJ Gen Intern Med200621772272716808773
  • SudoASanoTHorikawaKYamakawaTShiDUchidaAThe incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective studyJ Orthop Surg (Hong Kong)200311217417714676343
  • National Institute for Health and Clinical ExcellenceVenous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia TestingManchester, UKNational Institute for Health and Clinical Excellence2012
  • WeitzJIEikelboomJWSamamaMMAmerican College of Chest PhysiciansNew Antithrombotic Drugs: Antithrombotic Therapy and Prevention of Thrombosis9th ed American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e120Se151S22315258
  • SørensenHTHorvath-PuhoEPedersenLBaronJAPrandoniPVenous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort studyLancet200737096011773177918037081
  • GaliotoNJDanleyDLVan MaanenRJRecurrent venous thromboembolismAm Fam Physician201183329330021302870
  • Falck-YtterYFrancisCWJohansonNAAmerican College of Chest PhysiciansPrevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy and Prevention of Thrombosis9th ed American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e278Se325S22315265
  • GeertsWHBergqvistDPineoGFAmerican College of Chest PhysiciansPrevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines8th ed Chest2008133Suppl 6381S453S18574271
  • Lixiana [package insert]Tokyo, JapanDaiichi Sankyo Company, Ltd2011
  • RaskobGBüllerHPrinsMEdoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study – methodological implications for clinical trialsJ Thromb Haemost20131171287129423574579
  • RuffCTGiuglianoRPAntmanEMEvaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)Am Heart J2010160463564120934556
  • FurugohriTIsobeKHondaYDU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesJ Thromb Haemost2008691542154918624979
  • FujiTFujitaSTachibanaSKawaiYA dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplastyJ Thromb Haemost20108112458246820723033
  • RaskobGCohenATErikssonBIOral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response studyThromb Haemost2010104364264920589317
  • FujiTFujitaSTachibanaSEfficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V trial [Abstract]Blood20101163320
  • FujiTWangCJFujitaSEdoxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial [Abstract]Pathophysiol Haemost Thromb201037OC297
  • FujitaSFujiTTachibanaSNakamuraMKawaiYSafety and efficacy of edoxaban in patients undergoing hip fracture surgery [Abstract]Pathophysiol Haemost Thromb201037P366
  • Ministry of Health, Labor and WelfareGuidelines for Implementation of Early Post-Marketing Phase Vigilance (EPPV) for Prescription Drugs2006 Japanese. Available from http://www.info.pmda.go.jp/shinyaku/file/s20060324-001.pdfAccessed on September 11, 2013
  • International Federation of Pharmaceutical Manufacturers and AssociationsMedical Dictionary for Regulatory ActivitiesMedDRA/J Version 14.12011 Available from: http://www.meddra.org/sites/default/files/guidance/file/intguide_14_1_english.pdfAccessed September 11, 2013
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human UseICH Harmonised Tripartite Guideline. Post-Approval Safety Data Management: Definitions and Standards for Expediting Reporting E2DGeneva, SwitzerlandInternational Conference on Harmonisation2003 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdfAccessed April 3, 2013
  • NagaseYYasunagaHHoriguchiHRisk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in JapanJ Bone Joint Surg Am20119324e14622258781
  • FujiTFujitaSTachibanaSKawaiYEdoxaban versus enoxaparin for the prevention of venous thromboembolism: pooled analysis of venous thromboembolism and bleeding from STARS E-3 and STARS J-VBlood201111821208 Available from: https://ash.confex.com/ash/2011/webprogram/Paper39023.htmlAccessed September 11, 2013
  • KurodaYHotodaHNishikawaYNishiwakiAPost-Marketing Safety Experience with Edoxaban in Japan for Thromboprophylaxis Following Major Orthopedic SurgeryBlood20121204697 (Abstract). Available from: http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/4697?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=post-marketing&searchid=1&FIRSTINDEX=0&volume=120&issue=21&resourcetype=HWCITAccessed September 27, 2013